Bruna Pellini

Immunotherapy for Advanced Non–Small Cell Lung Cancer: A Decade of Progress

Misty Dawn Shields, Julian A. Marin‐Acevedo, Bruna Pellini · American Society of Clinical Oncology Educational Book · 2021 · 133 citations · Full text

Abstract PR014: Preliminary safety and anti-tumor activity of RMC-6291, a first-in-class, tri-complex KRASG12C(ON) inhibitor, in patients with or without prior KRASG12C(OFF) inhibitor treatment

Pasi A. Jänne, Frédéric Bigot, Kyriakos P. Papadopoulos et al. · Molecular Cancer Therapeutics · 2023 · 50 citations

Preliminary Safety, Pharmacotherapy, Tumor Biology +18

ctDNA MRD Detection and Personalized Oncogenomic Analysis in Oligometastatic Colorectal Cancer From Plasma and Urine

Bruna Pellini, Nadja Pejovic, Wenjia Feng et al. · JCO Precision Oncology · 2021 · 45 citations · Full text

Circulating Tumor DNA Monitoring on Chemo-immunotherapy for Risk Stratification in Advanced Non–Small Cell Lung Cancer

Bruna Pellini, Russell W. Madison, Merrida Childress et al. · Clinical Cancer Research · 2023 · 41 citations · Full text

A Multicenter Open-Label Randomized Phase II Study of Osimertinib With and Without Ramucirumab in Tyrosine Kinase Inhibitor–Naïve <i>EGFR</i> -Mutant Metastatic Non–Small Cell Lung Cancer (RAMOSE trial)

Xiuning Le, Jyoti D. Patel, Elaine Shum et al. · Journal of Clinical Oncology · 2024 · 33 citations · Full text